Onconetix, Inc. Common Stock, Value, Issued
Onconetix, Inc. (ONCO) had Common Stock, Value, Issued of $38 as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-13
- 2026-06-30: Common Stock, Value, Issued $38.00.
- 2026-03-31: Common Stock, Value, Issued $27.00.
- 2025-12-31: Common Stock, Value, Issued $3.00; Common Stock, Value, Issued as first filed $15.00.
- 2025-09-30: Common Stock, Value, Issued $15.00.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $38.00 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $27.00 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $3.00 10-Q · filed 2026-05-13 | $15.00 10-K · filed 2026-03-13 |
| 2025-09-30 | $15.00 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $10.00 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $368.00 10-Q · filed 2025-06-12 | |
| 2024-12-31 | $1.00 10-K · filed 2026-03-13 | $118.00 10-K · filed 2025-06-02 |
| 2024-09-30 | $83.00 10-Q · filed 2024-12-10 | |
| 2024-06-30 | $228.00 10-Q · filed 2024-08-29 | |
| 2024-03-31 | $228.00 10-Q · filed 2024-05-20 | |
| 2023-12-31 | $6.00 10-K · filed 2025-06-02 | $228.00 10-K · filed 2024-04-11 |
| 2023-09-30 | $183.00 10-Q · filed 2023-11-17 | |
| 2023-06-30 | $169.00 10-Q · filed 2023-10-20 | |
| 2023-03-31 | $164.00 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $157.00 10-K · filed 2024-04-11 | |
| 2022-09-30 | $147.00 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $122.00 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $110.00 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $32.00 10-K · filed 2023-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |